These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34398468)

  • 21. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.
    Seif El Nasr H; Shaker OG; Fawzi MM; El-Hanafi G
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):103-8. PubMed ID: 22151832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypopigmented mycosis fungoides in an adolescent Turkish boy.
    Gülekon A; Ozsoy E; Gürer MA; Ataoģlu O
    Int J Dermatol; 2005 Sep; 44(9):795-6. PubMed ID: 16135159
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypopigmented mycosis fungoides].
    Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
    Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: A pilot study.
    Ibrahim MA; Mohamed A; Soltan MY
    Indian J Dermatol Venereol Leprol; 2021; 87(6):819-825. PubMed ID: 31857520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypopigmented patches on the skin.
    Juhas E; English JC
    JAMA; 2013 Jan; 309(4):392-3. PubMed ID: 23340641
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypopigmented patches in a caucasian male: a quiz.
    Costa IM; Queiroz Zancanaro PC
    Acta Derm Venereol; 2010; 90(1):109-11. PubMed ID: 20107748
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of hypopigmented mycosis fungoides with granulomatous slack skin.
    Cui W; Wang S; Xu J
    Int J Dermatol; 2024 May; 63(5):690-691. PubMed ID: 38520067
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypopigmented mycosis fungoides.
    Whitmore SE; Simmons-O'Brien E; Rotter FS
    Arch Dermatol; 1994 Apr; 130(4):476-80. PubMed ID: 8166485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adolescence mycosis fungoides: an unusual presentation with hypopigmentation.
    el-Hoshy K; Hashimoto K
    J Dermatol; 1995 Jun; 22(6):424-7. PubMed ID: 7650241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides.
    Petit T; Cribier B; Bagot M; Wechsler J
    Eur J Dermatol; 2003; 13(4):410-2. PubMed ID: 12948929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides.
    Magro CM; Hagen JW; Crowson AN; Liu YC; Mihm M; Drucker NM; Yassin AH
    J Dermatol; 2014 Jul; 41(7):609-17. PubMed ID: 24806661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypopigmented mycosis fungoides. Speculations about the mechanism of hypopigmentation.
    Goldberg DJ; Schinella RS; Kechijian P
    Am J Dermatopathol; 1986 Aug; 8(4):326-30. PubMed ID: 3766921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation.
    Xiang W; Xu A; Xu J; Bi Z; Shang Y; Ren Q
    Lasers Med Sci; 2010 Jul; 25(4):551-8. PubMed ID: 20180143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypopigmented T-cell dyscrasia evolving to hypopigmented mycosis fungoides during etanercept therapy.
    Chuang GS; Wasserman DI; Byers HR; Demierre MF
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S121-2. PubMed ID: 19119122
    [No Abstract]   [Full Text] [Related]  

  • 36. CD8+ T Lymphocytes in Hypopigmented Mycosis Fungoides: Malignant Cells or Reactive Clone?
    Cao S; Kruglov O; Akilov OE
    J Invest Dermatol; 2023 Mar; 143(3):521-524.e3. PubMed ID: 36116507
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycosis fungoides presenting as areas of hypopigmentation: a report of three cases.
    Zackheim HS; Epstein EH; Grekin DA; McNutt NS
    J Am Acad Dermatol; 1982 Mar; 6(3):340-5. PubMed ID: 7068962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic profile of hypopigmented mycosis fungoides in India.
    Koorse S; Tirumalae R; Yeliur IK; Jayaseelan E
    Am J Dermatopathol; 2012 Apr; 34(2):161-4. PubMed ID: 22240772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypopigmented Mycosis Fungoides: A Clinical and Histopathology Analysis in 9 Children.
    Chen Y; Xu J; Qiu L; Fu L; Liang Y; Wei L; Xiang X; Wang Z; Xu Z; Ma L
    Am J Dermatopathol; 2021 Apr; 43(4):259-265. PubMed ID: 33201017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological progression of a mycosis fungoides mimic to classic vitiligo.
    Kaskas NM; DiGiorgio C; Nicotri T; Hooper D; Grimes P
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1856-7. PubMed ID: 24813942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.